{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:55:19Z","timestamp":1773147319505,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,4,4]],"date-time":"2009-04-04T00:00:00Z","timestamp":1238803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10689-009-9242-z","type":"journal-article","created":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T14:14:41Z","timestamp":1238768081000},"page":"277-287","source":"Crossref","is-referenced-by-count":29,"title":["Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting"],"prefix":"10.1007","volume":"8","author":[{"given":"Debra","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Lee","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Miesfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,4]]},"reference":[{"issue":"4","key":"9242_CR1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2003.05.096","volume":"21","author":"HT Lynch","year":"2003","unstructured":"Lynch HT, Snyder CL et al (2003) Hereditary breast ovarian cancer at the bedside: role of the medical oncologist. J Clin Oncol 21(4):740\u2013753. doi: 10.1200\/JCO.2003.05.096","journal-title":"J Clin Oncol"},{"issue":"9","key":"9242_CR2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665\u2013676. doi: 10.1038\/nrc1431","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"9242_CR3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676\u2013689. doi: 10.1086\/301749","journal-title":"Am J Hum Genet"},{"issue":"5","key":"9242_CR4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130. doi: 10.1086\/375033","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9242_CR5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","volume":"61","author":"DF Easton","year":"1997","unstructured":"Easton DF, Steele L et al (1997) Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12\u201313. Am J Hum Genet 61(1):120\u2013128. doi: 10.1086\/513891","journal-title":"Am J Hum Genet"},{"issue":"20","key":"9242_CR6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401\u20131408. doi: 10.1056\/NEJM199705153362001","journal-title":"N Engl J Med"},{"issue":"15","key":"9242_CR7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"The Breast Cancer Linkage Consortium","year":"1999","unstructured":"The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310\u20131316. doi: 10.1093\/jnci\/91.15.1310","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"9242_CR8","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94(18):1365\u20131372","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"9242_CR9","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94(18):1358\u20131365","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"9242_CR10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329\u20131333. doi: 10.1200\/JCO.2006.09.1066","journal-title":"J Clin Oncol"},{"issue":"5","key":"9242_CR11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7326\/0003-4819-143-5-200509060-00011","volume":"143","author":"U.S. Preventive Services Task Force","year":"2005","unstructured":"U.S. Preventive Services Task Force (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 143(5):355\u2013361","journal-title":"Ann Intern Med"},{"issue":"8","key":"9242_CR12","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","volume":"26","author":"ND Kauff","year":"2008","unstructured":"Kauff ND, Domchek SM et al (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8):1331\u20131337. doi: 10.1200\/JCO.2007.13.9626","journal-title":"J Clin Oncol"},{"issue":"19","key":"9242_CR13","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2005.10.080","volume":"23","author":"LJ Herrinton","year":"2005","unstructured":"Herrinton LJ, Barlow WE et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23(19):4275\u20134286. doi: 10.1200\/JCO.2005.10.080","journal-title":"J Clin Oncol"},{"issue":"3","key":"9242_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","volume":"7","author":"SM Domchek","year":"2006","unstructured":"Domchek SM, Friebel TM et al (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7(3):223\u2013229. doi: 10.1016\/S1470-2045(06)70585-X","journal-title":"Lancet Oncol"},{"issue":"9","key":"9242_CR15","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/ijc.21536","volume":"118","author":"J Gronwald","year":"2006","unstructured":"Gronwald J, Tung N et al (2006) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118(9):2281\u20132284. doi: 10.1002\/ijc.21536","journal-title":"Int J Cancer"},{"issue":"21","key":"9242_CR16","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1200\/JCO.2005.00.133","volume":"23","author":"M Epplein","year":"2005","unstructured":"Epplein M, Koon KP et al (2005) Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. J Clin Oncol 23(21):4713\u20134718. doi: 10.1200\/JCO.2005.00.133","journal-title":"J Clin Oncol"},{"issue":"2","key":"9242_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1207\/S15430154JCE1802_11","volume":"18","author":"LC Friedman","year":"2003","unstructured":"Friedman LC, Cooper HP et al (2003) Primary care physicians\u2019 attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results. J Cancer Educ 18(2):91\u201394. doi: 10.1207\/S15430154JCE1802_11","journal-title":"J Cancer Educ"},{"issue":"4","key":"9242_CR18","first-page":"295","volume":"12","author":"L Wideroff","year":"2003","unstructured":"Wideroff L, Freedman AN et al (2003) Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev 12(4):295\u2013303","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"9242_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.a.20431","volume":"125","author":"ST Tinley","year":"2004","unstructured":"Tinley ST, Houfek J et al (2004) Screening adherence in BRCA1\/2 families is associated with primary physicians\u2019 behavior. Am J Med Genet 125(1):5\u201311. doi: 10.1002\/ajmg.a.20431","journal-title":"Am J Med Genet"},{"issue":"1","key":"9242_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/pmed.2000.0684","volume":"31","author":"C Lerman","year":"2000","unstructured":"Lerman C, Hughes C et al (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1\/2 testing. Prev Med 31(1):75\u201380. doi: 10.1006\/pmed.2000.0684","journal-title":"Prev Med"},{"issue":"3","key":"9242_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajmg.a.10102","volume":"118","author":"JR Botkin","year":"2003","unstructured":"Botkin JR, Smith KR et al (2003) Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2\u00a0years post testing. Am J Med Genet 118(3):201\u2013209. doi: 10.1002\/ajmg.a.10102","journal-title":"Am J Med Genet"},{"issue":"9","key":"9242_CR22","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2003.09.052","volume":"21","author":"H Meijers-Heijboer","year":"2003","unstructured":"Meijers-Heijboer H, Brekelmans CT et al (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21(9):1675\u20131681. doi: 10.1200\/JCO.2003.09.052","journal-title":"J Clin Oncol"},{"issue":"10 Pt 1","key":"9242_CR23","first-page":"1115","volume":"11","author":"BN Peshkin","year":"2002","unstructured":"Peshkin BN, Schwartz MD et al (2002) Utilization of breast cancer screening in a clinically based sample of women after BRCA1\/2 testing. Cancer Epidemiol Biomarkers Prev 11(10 Pt 1):1115\u20131118","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"9242_CR24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","volume":"20","author":"L Scheuer","year":"2002","unstructured":"Scheuer L, Kauff N et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20(5):1260\u20131268. doi: 10.1200\/JCO.20.5.1260","journal-title":"J Clin Oncol"},{"issue":"2","key":"9242_CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1013800409238","volume":"71","author":"C Isaacs","year":"2002","unstructured":"Isaacs C, Peshkin BN et al (2002) Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat 71(2):103\u2013112. doi: 10.1023\/A:1013800409238","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"9242_CR26","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1200\/JCO.2007.12.6078","volume":"26","author":"KA Metcalfe","year":"2008","unstructured":"Metcalfe KA, Jan Lubinski J et al (2008) Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the hereditary breast cancer clinical study group. J Clin Oncol 26(7):1093\u20131097. doi: 10.1200\/JCO.2007.12.6078","journal-title":"J Clin Oncol"},{"issue":"3","key":"9242_CR27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1200\/JCO.2005.02.2368","volume":"24","author":"CH Barcenas","year":"2006","unstructured":"Barcenas CH, Hosain GM et al (2006) Assessing BRCA carrier probabilities in extended families. J Clin Oncol 24(3):354\u2013360. doi: 10.1200\/JCO.2005.02.2368","journal-title":"J Clin Oncol"},{"issue":"4","key":"9242_CR28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","volume":"24","author":"PA James","year":"2006","unstructured":"James PA, Doherty R et al (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 24(4):707\u2013715. doi: 10.1200\/JCO.2005.01.9737","journal-title":"J Clin Oncol"},{"issue":"12","key":"9242_CR29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","volume":"277","author":"W Burke","year":"1997","unstructured":"Burke W, Daly M, Garber J et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 277(12):997\u20131003. doi: 10.1001\/jama.277.12.997","journal-title":"JAMA"},{"key":"9242_CR30","unstructured":"NCCN Breast Cancer Panel (2000) NCCN practice guidelines for genetics\/familial high-risk screening. Breast, Version 1"},{"issue":"1","key":"9242_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.a.20431","volume":"125A","author":"S Tinley","year":"2004","unstructured":"Tinley S et al (2004) Screening adherence in BRCA 1\/2 families is associated with primary physicians\u2019 behavior. Am J Med Genet 125A(1):5\u201311. doi: 10.1002\/ajmg.a.20431","journal-title":"Am J Med Genet"},{"issue":"23","key":"9242_CR32","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra012284","volume":"348","author":"R Wooster","year":"2003","unstructured":"Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348(23):2339\u20132347. doi: 10.1056\/NEJMra012284","journal-title":"N Engl J Med"},{"issue":"1","key":"9242_CR33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.GIM.0000151155.36470.FF","volume":"7","author":"MR McClain","year":"2005","unstructured":"McClain MR, Palomaki GE et al (2005) Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications. Genet Med 7(1):28\u201333. doi: 10.1097\/01.GIM.0000151155.36470.FF","journal-title":"Genet Med"},{"issue":"24","key":"9242_CR34","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","volume":"275","author":"C Lerman","year":"1996","unstructured":"Lerman C, Narod S et al (1996) BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 275(24):1885\u20131892. doi: 10.1001\/jama.275.24.1885","journal-title":"JAMA"},{"issue":"21","key":"9242_CR35","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633\u20131637","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"9242_CR36","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM et al (2002) Risk-reducing salpingooophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609\u20131615. doi: 10.1056\/NEJMoa020119","journal-title":"N Engl J Med"},{"issue":"18","key":"9242_CR37","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","volume":"286","author":"MC King","year":"2001","unstructured":"King MC, Wieand S et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 286(18):2251\u20132256. doi: 10.1001\/jama.286.18.2251","journal-title":"JAMA"},{"issue":"20","key":"9242_CR38","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/archinte.166.20.2260","volume":"166","author":"K Armstrong","year":"2006","unstructured":"Armstrong K, Quistberg DA et al (2006) Prescription of tamoxifen for breast cancer prevention by primary care physicians. Arch Intern Med 166(20):2260\u20132265. doi: 10.1001\/archinte.166.20.2260","journal-title":"Arch Intern Med"},{"issue":"3","key":"9242_CR39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1370\/afm.284","volume":"3","author":"R Taylor","year":"2005","unstructured":"Taylor R, Taguchi K (2005) Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump. Ann Fam Med 3(3):242\u2013247. doi: 10.1370\/afm.284","journal-title":"Ann Fam Med"},{"issue":"14","key":"9242_CR40","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/jnci\/93.14.1095","volume":"93","author":"MJ Stoutjesdijk","year":"2001","unstructured":"Stoutjesdijk MJ, Boetes C et al (2001) Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93(14):1095\u20131102. doi: 10.1093\/jnci\/93.14.1095","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"9242_CR41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelman CT et al (2004) Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5):427\u2013437. doi: 10.1056\/NEJMoa031759","journal-title":"N Engl J Med"},{"issue":"9473","key":"9242_CR42","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach MO, Boggis CR et al (2005) Screening with magnetic resonance imaging and mammography in a UK population at high familial risk of breast cancer : a prospective multicentre cohort study (MARIBS). Lancet 365(9473):1769\u20131778. doi: 10.1016\/S0140-6736(05)66481-1","journal-title":"Lancet"},{"key":"9242_CR43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317\u20131325. doi: 10.1001\/jama.292.11.1317","journal-title":"JAMA"},{"key":"9242_CR44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D et al (2007) American cancer society guidelines breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75\u201389","journal-title":"CA Cancer J Clin"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-009-9242-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9242-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:45:59Z","timestamp":1559252759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-009-9242-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9242"],"URL":"https:\/\/doi.org\/10.1007\/s10689-009-9242-z","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,4]]}}}